Login / Signup

Regional Citrate Anticoagulation in Continuous Renal Replacement Therapy: Is Metabolic Fear the Enemy of Logic? A Systematic Review and Meta-Analysis of Randomised Controlled Trials.

Rita JacobsWalter VerbruggheKarolien DamsElla RoelantMarie Madeleine CouttenyeDirk DevroeyPhilippe G Jorens
Published in: Life (Basel, Switzerland) (2023)
regional citrate anticoagulation is a safe anticoagulant for critically ill patients who require CRRT, as no significant differences were found in metabolic complications between the groups. Additionally, citrate has a lower risk of bleeding and circuit loss than heparin.
Keyphrases
  • atrial fibrillation
  • venous thromboembolism
  • acute kidney injury
  • growth factor
  • prefrontal cortex